theboardiQ Ace Board Readiness Path - Step 2
Self paced, Contextual and Optimized to present the best version of you for Board and Executive Roles
Pharma and Healthcare
Pharma/Healthcare
Step 1 - Complete self assessment
There are 8 -12 skills that every candidate is evaluated on for board roles. theboardiQ Ace Contextual Skill Assessment is the first step to contextualize your skills and experience to set you up for the relevant Ace Board Readiness Path. This is based on research findings of the Glass Lewis Method of Board Selection Process of Public Companies.
Once you have completed the self assessment, you will be directed to make your own customized self paced board readiness path. Your place, your pace, your time. 95% recommendations are free. Content curated by theboardiQ from top MOOCs, Universities and Institutions (UN and WEF). The modules have assessments / quizzes leading upto certification by theboardiQ Academy.
Step 2 - Optimize by relevance
Based on the insights and self assessment in Step 1, make your own customized self paced board readiness path. The modules have assessments / quizzes that will help determine your skill enhancement after the relevant training, leading to certification by theboardiQ Academy
Your place, your pace, your time
Primary Skills
Risk Management
This is the most critical skill for a healthcare board. The industry faces an array of complex and high-stakes risks, including the failure of clinical trials, regulatory approval delays, product liability, and a volatile political environment. A board with deep risk management expertise is essential for navigating these challenges, protecting both patients and the company's financial health.
This skill is non-negotiable. The healthcare and pharmaceutical industries are heavily regulated by bodies like the FDA, and any breach of ethics or compliance can result in massive fines, legal action, and a complete loss of public trust. A board with a strong focus on ethics and compliance ensures the company adheres to the highest standards, from drug safety to data privacy.
Business Ethics and Compliance
Finance / Capital Allocation
The development of new drugs and medical technologies is a capital-intensive, high-risk endeavor. A board with expertise in finance and capital allocation is crucial for making strategic decisions about where to invest billions in research and development, which companies to acquire, and how to manage the company's balance sheet in a volatile market.
The healthcare industry is increasingly driven by technology, from digital health records to AI-powered diagnostics. A board needs a deep understanding of these systems to guide the company's digital transformation. In parallel, with sensitive patient data being a prime target, a strong background in cybersecurity is essential to protect against breaches and maintain patient trust.